Your browser doesn't support javascript.
loading
Beneficial effects of JAK inhibitor therapy in Systemic Mastocytosis.
Dowse, Robin; Ibrahim, Maria; McLornan, Donal P; Moonim, Mufaddal T; Harrison, Claire N; Radia, Deepti H.
Afiliação
  • Dowse R; Department of Haematological Medicine, King's College NHS Foundation Trust, London, UK.
  • Ibrahim M; Department of Haematological Medicine, King's College NHS Foundation Trust, London, UK.
  • McLornan DP; Department of Haematological Medicine, King's College NHS Foundation Trust, London, UK.
  • Moonim MT; Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Harrison CN; Department of Pathology, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
  • Radia DH; Department of Haematology, Guy's and St. Thomas' NHS Foundation Trust, London, UK.
Br J Haematol ; 176(2): 324-327, 2017 01.
Article em En | MEDLINE | ID: mdl-26847591
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mastocitose Sistêmica / Inibidores de Janus Quinases Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Mastocitose Sistêmica / Inibidores de Janus Quinases Idioma: En Ano de publicação: 2017 Tipo de documento: Article